Schenkel, L.C.; Mathew, J.; Hirte, H.; Provias, J.; Paré, G.; Chong, M.; Grafodatskaya, D.; McCready, E.
Evaluation of DNA Methylation Array for Glioma Tumor Profiling and Description of a Novel Epi-Signature to Distinguish IDH1/IDH2 Mutant and Wild-Type Tumors. Genes 2022, 13, 2075.
https://doi.org/10.3390/genes13112075
AMA Style
Schenkel LC, Mathew J, Hirte H, Provias J, Paré G, Chong M, Grafodatskaya D, McCready E.
Evaluation of DNA Methylation Array for Glioma Tumor Profiling and Description of a Novel Epi-Signature to Distinguish IDH1/IDH2 Mutant and Wild-Type Tumors. Genes. 2022; 13(11):2075.
https://doi.org/10.3390/genes13112075
Chicago/Turabian Style
Schenkel, Laila C., Joseph Mathew, Hal Hirte, John Provias, Guillaume Paré, Michael Chong, Daria Grafodatskaya, and Elizabeth McCready.
2022. "Evaluation of DNA Methylation Array for Glioma Tumor Profiling and Description of a Novel Epi-Signature to Distinguish IDH1/IDH2 Mutant and Wild-Type Tumors" Genes 13, no. 11: 2075.
https://doi.org/10.3390/genes13112075
APA Style
Schenkel, L. C., Mathew, J., Hirte, H., Provias, J., Paré, G., Chong, M., Grafodatskaya, D., & McCready, E.
(2022). Evaluation of DNA Methylation Array for Glioma Tumor Profiling and Description of a Novel Epi-Signature to Distinguish IDH1/IDH2 Mutant and Wild-Type Tumors. Genes, 13(11), 2075.
https://doi.org/10.3390/genes13112075